Endoplasmic Reticulum Proteostasis in Health and Disease - Oslo Symposium 2019

This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.

Mitochondria, illustration
Photo: Jørgen Sikkeland, UiO.

Department of Molecular Medicine, Faculty of Medicine, and the Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, in collaboration with NBS Oslo, is happy to present a one-day symposium on the most recent discoveries in the field of ER Proteostasis.


Download program (pdf)



Proteostasis, refers to the competing and integrated biological pathways within cells that control the biogenesis, folding, trafficking and degradation of proteins present within and outside the cell. It is central to normal physiology as well as understanding the cause of many diseases such as cancer and neurodegenerative disorders.

The most central organelle in proteostasis is the endoplasmic reticulum (ER). ER mediated proteostasis has a key role during normal development, healthy aging, and resistance to various environmental stresses.

Mechanisms by which ER proteostasis is achieved include regulated protein translation, chaperone assisted protein folding and modulation of protein degradation pathways. Adjusting each of these mechanisms when needed is essential to maintain normal cellular function.

Recent research shows that dysregulation of proteostasis impacts a plethora of diseases and thus important nodes of its regulation may provide therapeutic targets.

Our sponsors

Published Sep. 12, 2019 1:15 PM - Last modified July 12, 2022 10:45 PM